Aurinia Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Aurinia Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 15660% to $50,118,000. The net income raised on -$102,680,000 and profit margin reached -205%. Total operating expenses were $97,272,000.
Profit Margin
| 2011 | 927.52K | -2.40M | -259.56% |
|---|---|---|---|
| 2012 | 6.15M | -9.73M | -158.13% |
| 2013 | 948.56K | -2.54M | -268.42% |
| 2014 | 278K | -16.64M | -5988.13% |
| 2015 | 235K | -18.60M | -7917.87% |
| 2016 | 173K | -23.29M | -13465.32% |
| 2017 | 420K | -70.79M | -16855.24% |
| 2018 | 463K | -64.12M | -13848.81% |
| 2019 | 318K | -123.84M | -38945.28% |
| 2020 | 50.11M | -102.68M | -204.88% |
AUP.TO Income Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 50.11M | 318K | 463K | 420K | 173K | 235K | 278K | 948.56K | 6.15M | 927.52K |
Cost of revenue | 50.32M | 52.86M | 41.38M | 33.93M | 14.53M | 15.99M | 9.14M | 1.93M | 5.55M | 185.11K |
Gross profit | -209K | -52.54M | -40.91M | -33.51M | -14.36M | -15.75M | -8.87M | -986.12K | 602.11K | 742.40K |
Operating exp. | ||||||||||
Research and development | 0 | 0 | 0 | 33.93M | 0 | 0 | 0 | 1.93M | 0 | 3.47M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 97.27M | 23.70M | 15.23M | 13.55M | 8.44M | 7.82M | 8.41M | 3.04M | 6.07M | 7.18M |
Operating income | -97.48M | -76.25M | -56.15M | -47.06M | -22.81M | -23.58M | -17.28M | -4.03M | -5.46M | -6.43M |
Other income (expenses), net | -5.29M | -47.45M | -7.88M | -23.72M | -481K | 4.97M | 635K | -2.37M | -4.27M | -4.03M |
Income before tax | -102.77M | -123.70M | -64.04M | -70.79M | -23.29M | -18.60M | -16.64M | -6.40M | -9.73M | -2.40M |
Income tax expense | -94K | 144K | 73K | -23.72M | -481K | 4.97M | 665K | -3.85M | 0 | 0 |
Net income | -102.68M | -123.84M | -64.12M | -70.79M | -23.29M | -18.60M | -16.64M | -2.54M | -9.73M | -2.40M |
Earnings per share | ||||||||||
Basic EPS | -1.1 | -1.33 | -0.76 | -0.92 | -0.66 | -0.58 | -0.57 | -0.4 | -2.51 | -0.48 |
Diluted EPS | -1.1 | -1.33 | -0.76 | -0.92 | -0.66 | -0.58 | -0.57 | -0.4 | -2.51 | -0.48 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |